Florian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, Christian Bernreuther, Franziska Büscheck, Till S Clauditz, Andrea Hinsch, Frank Jacobsen, Andreas M Luebke, Stefan Steurer, Claudia Hube-Magg, Martina Kluth, Andreas H Marx, Till Krech, Patrick Lebok, Christoph Fraune, Eike Burandt, Guido Sauter, Ronald Simon, Sarah Minner
Androgen receptor (AR) is a transcription factor expressed in various normal tissues and is a therapeutic target for prostate and possibly other cancers. A TMA containing 18,234 samples from 141 different tumor types/subtypes and 608 samples of 76 different normal tissue types was analyzed by immunohistochemistry. AR positivity was found in 116 tumor types including 66 tumor types (46.8%) with ≥1 strongly positive tumor. Moderate/strong AR positivity was detected in testicular sex cord-stromal tumors (93...
April 25, 2024: Biomedicines